Coronary events
Disease3 papers2 findings
- Humans2
Associations
2GLP-1 receptor agonists
downin humans1Low certainty
1 study
GLP-1 receptor agonists
downin humans1Low certainty
GLP-1 receptor agonists lower the risk of coronary events in humans.
Humans
Prior GLP-1RA or Tirzepatide Use and Early Cardiorenal Outcomes After Metabolic and Bariatric Surgery · The American journal of medicine · 14 Sep 2026
Total plaque volume
upin humans1HR 6.36
1 study
Total plaque volume
upin humans1HR 6.36
Total plaque volume predicts coronary events in humans (HR 6.36, 95% CI: 3.00-13.52).
Humansgeneral population without prior atherosclerotic cardiovascular diseasemedian of 7.8 yearsn = 23,314
Incremental Predictive Value of Deep Learning-Quantified Coronary Atherosclerotic Volume: A SCAPIS Cohort Analysis · JACC. Cardiovascular imaging · 21 Aug 2026
Latest
10The American Journal of MedicineHumans
Prior GLP-1RA or Tirzepatide Use and Early Cardiorenal Outcomes After Metabolic and Bariatric Surgery
Journal of Clinical LipidologyHuman trial
Fish oil supplementation reduces the CERT2 risk score in adults with increased cardiometabolic risk: Findings from the MoKaRi trial
The Cochrane Database of Systematic ReviewsReview
Long-term hormone therapy for perimenopausal and postmenopausal women
JACC Cardiovascular ImagingHumans
Incremental Predictive Value of Deep Learning-Quantified Coronary Atherosclerotic Volume: A SCAPIS Cohort Analysis
European Heart Journal Imaging Methods and PracticeReview
Non-calcified plaque volume assessed by coronary computed tomographic angiography: prognostic significance, reproducibility, and temporal progression
Journal of Atherosclerosis and ThrombosisReview
Targeting Dyslipidemia in Ischemic Stroke: Pathophysiology, Clinical Evidence, and Future Perspectives
AHA Scientific Sessions 2025 AbstractHumans
Cross-species single-cell reconstruction of atherosclerosis reveals predictive monocytes for acute coronary events
AHA Scientific Sessions 2025 AbstractHumans
Utility of Polygenic Risk Scores at Identifying Subgroup with Greater Benefit From Statins
AHA Scientific Sessions 2025 AbstractHumans